Optimax Holdings (0222) Fundamentals 2026 — P/E 21.7x, Revenue Analysis | SniperIQ
Optimax Holdings (0222) is a MY-listed Healthcare company in Medical - Care Facilities with a market capitalization of RM285M, trading at RM0.53 on the KLS. This SniperIQ fundamentals page covers Optimax Holdings's valuation (P/E 21.7x, P/B 3.9x), profitability (net margin 9.7%), revenue (RM136M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Optimax Holdings's market cap?
Optimax Holdings (0222) has a market capitalization of approximately RM285M, trading at RM0.53 on the KLS. Market cap moves with the live share price.
What is Optimax Holdings's P/E ratio?
Optimax Holdings's trailing twelve-month P/E ratio is 21.7x, with a price-to-book (P/B) of 3.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Optimax Holdings?
Optimax Holdings runs a net profit margin of 9.7%, a gross margin of 52.5%, and an operating margin of 16.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Optimax Holdings generate?
Optimax Holdings reported revenue of RM136M for fiscal year 2025, with net income of RM14M and earnings per share (EPS) of 0.0253. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Optimax Holdings pay a dividend?
Optimax Holdings offers a trailing dividend yield of about 2.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Optimax Holdings financially healthy?
Optimax Holdings carries a debt-to-equity ratio of 0.66x and a current ratio of 1.58x, with a market beta of 0.17. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Optimax Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Optimax Holdings (0222) the key facts are: market cap RM285M, P/E 21.7x, revenue RM136M, 52-week range 0.5-0.715. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Optimax Holdings's full fundamentals live
Get Optimax Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.